The Oncologist -- Vienna Symposium -- Faculty

<< Return to Symposium Home Page

Active Presentations

Forum on Anemia in Hematologic Malignancies

Forum on Anemia in Lung Cancer

Quality of Life Among Patients with Cancer—the Impact of Anemia and Fatigue

Forum on Anemia in Breast Cancer

Forum on Optimal Management of Anemia

Faculty

Forthcoming Presentations

Forum on Anemia in Gynecologic Cancer
August 2004

Forum on Anemia in Gastrointestinal and Colorectal Cancer
TBA

Supported by an educational grant from A division of Janssen-Cilag

© 2004 by AlphaMed Press.

2003 Vienna Symposium

Vienna Symposium Faculty

<< Return to faculty page

Robert Milroy, M.D., for the Epoetin Alfa INT-49 Study Group
Dr. Milroy is a Consultant Respiratory Physician at Stobhill Hospital in Glasgow, Scotland. His major interests are in the clinical and research aspects of lung cancer. He is Chair of the West of Scotland Lung Cancer Research Group, Chair of the Scottish Lung Cancer Trials Group, a founding member of the British Thoracic Society Lung Cancer Special Interest Group, and a National Representative for the Intercollegiate Lung Cancer Working Party. Dr. Milroy has published extensively in the field of lung cancer, which includes co-authoring a book.
Forum on Anemia in Lung Cancer—Epoetin Alfa vs Best Standard Care in NSCLC Patients (213k)


	<< Return to Symposium Home Page Active Presentations Forum on Anemia in Hematologic Malignancies Forum on Anemia in Lung Cancer Quality of Life Among Patients with Cancer—the Impact of Anemia and Fatigue Forum on Anemia in Breast Cancer Forum on Optimal Management of Anemia Faculty Forthcoming Presentations Forum on Anemia in Gynecologic Cancer August 2004 Forum on Anemia in Gastrointestinal and Colorectal Cancer TBA Supported by an educational grant from A division of Janssen-Cilag © 2004 by AlphaMed Press.		2003 Vienna Symposium Vienna Symposium Faculty << Return to faculty page Robert Milroy, M.D., for the Epoetin Alfa INT-49 Study Group Dr. Milroy is a Consultant Respiratory Physician at Stobhill Hospital in Glasgow, Scotland. His major interests are in the clinical and research aspects of lung cancer. He is Chair of the West of Scotland Lung Cancer Research Group, Chair of the Scottish Lung Cancer Trials Group, a founding member of the British Thoracic Society Lung Cancer Special Interest Group, and a National Representative for the Intercollegiate Lung Cancer Working Party. Dr. Milroy has published extensively in the field of lung cancer, which includes co-authoring a book. Forum on Anemia in Lung Cancer—Epoetin Alfa vs Best Standard Care in NSCLC Patients (213k)